Lung Cancer (NSCLC)NCT07338474
Mobilization Before and After Video-Assisted Thoracoscopic Surgery Lobectomy/Segmentectomy
An observational study of Lung Cancer (NSCLC) and Perioperative Care, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.
Trial summary
To examine mobilization before/after Video-Assisted Thoracoscopic Surgery Lobectomy/Segmentectomy and further assess possible barriers to mobilization. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Lung Cancer (NSCLC), Perioperative Care, Enhanced Recovery After Surgery
- How many people
- 51 participants
- Where
- 1 siteDenmark
- Study dates
- 23 Aug 2024to 3 May 2025
- How long will I take part?
- 30 Days
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients undergoing VATS lobectomy/segmentectomy at the Department of Cardiothoracic Surgery, Rigshospitalet, Denmark, that adheres to the above inclusion/exclusion criterias
Who may be able to join
- Age > 18 years
- Able to understand written and spoken Danish language
- Signed written informed consent form.
- Patient planned to elective VATS lobectomy or segmentectomy
- Patients with the pre-operative examination done minimum 48 hours prior to surgery (to allow at least 48 hours of preoperative activity monitoring)
Who cannot join
- Patients with diagnoses (neurological, psychiatric, orthopedic etc.) that challenges postoperative mobilization and posture changes.
- Patient undergoing re-surgery
- Patients admitted to intensive care unit
- Patients with a conversion to open surgery
Trial locations and contacts
1 site in 1 country.
Denmark1 site
Department for Cardiothoracic Surgery, Rigshospitalet
Copenhagen, 2100
About this study
Official title: Postoperative Physical Activity and Posture in Patients Undergoing Enhanced Recovery Video-Assisted Thoracoscopic Lobectomy and Segmentectomy
To examine mobilization before/after Video-Assisted Thoracoscopic Surgery Lobectomy/Segmentectomy and further assess possible barriers to mobilization.
Read the detailed description
50 patients will be included in the study. Patients will wear a SENS motion, accelerometer for minimum 48 hours before surgery and until discharge (or maximum 7 days). Mobilization and posture will be measured 24h. Twice daily the patients will be assessed with a multidimensional questionnaire about barriers to mobilization.
- Keywords
- mobilization, ERAS, posture, minimizing complications, fast-track, lung-surgery, thoracic-surgery
- Medical subject headings
- Lung Neoplasms, Carcinoma, Non-Small-Cell Lung
What is being measured
The primary outcome is the main question the study is designed to answer.
Minutes spent supine, sitting and standing
Measured: Before surgery: From enrollment to surgery day (minimum 48 hours) and After surgery: From 3 hours post surgery and until discharge or maximum 7 days.
Secondary outcomes (4)
Time spent out of bed
Measured: Before surgery: From enrollment to surgery day (minimum 48 hours) and After surgery: From 3 hours post surgery and until discharge or maximum 7 days.
Pulmonary complications
Measured: Within 30 days
Length of hospital stay
Measured: Days counted after surgery. Day of surgery is day 0.
Reasons for not being mobilized (questionnaire)
Measured: Filled out twice daily on first and second postoperative day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jan 2026
- Study start23 Aug 2024
- Primary completion3 Apr 2025
- Study completion3 May 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Lung Cancer (NSCLC)Studies of the same condition, open and under way.
- More trials run by Copenhagen University Hospital, RigshospitaletThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 51 participants (actual)
- Target duration
- 30 Days
Sponsor and investigators
- Lead sponsor
- Copenhagen University Hospital, Rigshospitalet
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Lasse Visby, Copenhagen University Hospital, Rigshospitalet
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07338474
- Sponsor's protocol ID
- P-2024-17015
- Status last verified
- Jan 2026
- First submitted
- 1 Oct 2025
- Last updated
- 14 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Postoperative Physical Activity and Posture in Patients Undergoing Enhanced Recovery Video-Assisted Thoracoscopic Lobectomy and Segmentectomy
- ClinicalTrials.gov ID
- NCT07338474
- Acronym / sponsor ID
- P-2024-17015
- Keywords
- mobilization, ERAS, posture, minimizing complications, fast-track, lung-surgery, thoracic-surgery
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 51 participants (actual)
- Lead sponsor
- Copenhagen University Hospital, RigshospitaletUniversity, hospital or other
- Study start
- 23 Aug 2024 (actual)
- Primary completion
- 3 Apr 2025 (actual)
- Study completion
- 3 May 2025 (actual)
- First posted
- 14 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To examine mobilization before/after Video-Assisted Thoracoscopic Surgery Lobectomy/Segmentectomy and further assess possible barriers to mobilization.
Detailed description
50 patients will be included in the study. Patients will wear a SENS motion, accelerometer for minimum 48 hours before surgery and until discharge (or maximum 7 days). Mobilization and posture will be measured 24h. Twice daily the patients will be assessed with a multidimensional questionnaire about barriers to mobilization.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Target follow-up
- 30 Days
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients undergoing VATS lobectomy/segmentectomy at the Department of Cardiothoracic Surgery, Rigshospitalet, Denmark, that adheres to the above inclusion/exclusion criterias
Key inclusion criteria (5 listed)
- Age > 18 years
- Able to understand written and spoken Danish language
- Signed written informed consent form.
- Patient planned to elective VATS lobectomy or segmentectomy
- Patients with the pre-operative examination done minimum 48 hours prior to surgery (to allow at least 48 hours of preoperative activity monitoring)
Key exclusion criteria (4 listed)
- Patients with diagnoses (neurological, psychiatric, orthopedic etc.) that challenges postoperative mobilization and posture changes.
- Patient undergoing re-surgery
- Patients admitted to intensive care unit
- Patients with a conversion to open surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Minutes spent supine, sitting and standing
Time frame: Before surgery: From enrollment to surgery day (minimum 48 hours) and After surgery: From 3 hours post surgery and until discharge or maximum 7 days.
4 secondary outcomes
Time spent out of bed
Time frame: Before surgery: From enrollment to surgery day (minimum 48 hours) and After surgery: From 3 hours post surgery and until discharge or maximum 7 days.
Pulmonary complications
Time frame: Within 30 days
Length of hospital stay
Time frame: Days counted after surgery. Day of surgery is day 0.
Reasons for not being mobilized (questionnaire)
Time frame: Filled out twice daily on first and second postoperative day
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jan 2026.
- Individual participant dataSharing planned: No
Related trials for Lung Cancer (NSCLC)
Active, not recruitingPhase 1/2
A Beta-only IL-2 ImmunoTherapY Study
Advanced Solid Tumor, Unresectable Solid Tumor
RecruitingPhase 2/3
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Non-small Cell Lung Cancer
Recruiting
Understanding the Feasibility of a Co-designed Pre-radiotherapy Exercise Programme - A Single-arm Study
Lung Cancer
RecruitingPhase 2
Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)
Non-small Cell Lung Cancer, Non-small Cell Lung Cancer Stage I
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Lung Cancer (NSCLC) and Perioperative Care, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Minutes spent supine, sitting and standing (time frame: Before surgery: From enrollment to surgery day (minimum 48 hours) and After surgery: From 3 hours post surgery and until discharge or maximum 7 days.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2026.